Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | +3.79% | -1.48% | -28.85% |
13/05 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
08/05 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.85% | 20Cr | |
+16.41% | 7.92TCr | |
+7.70% | 872.08Cr | |
-16.83% | 478.98Cr | |
+47.36% | 462.18Cr | |
+1.74% | 382.39Cr | |
+14.51% | 233.24Cr | |
-26.23% | 219.75Cr | |
+15.63% | 209.63Cr | |
-34.87% | 203.91Cr |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Zevra Therapeutics Says Interim Data Show KP1077 for Idiopathic Hypersomnia Well-Tolerated at All Dose Levels